Condition
RCC, Renal Cell Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 RCC, Renal Cell Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (2), Taiwan (1), Brazil (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest RCC, Renal Cell Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cortical-plus-medullary versus medullary-only suturing for robot-assisted partial nephrectomy | — | Salvador, Estado de Bahia and 1 other locations | Recruiting | Sep 24, 2025 |
| Robot-assisted surgery for early-stage kidney tumors | — | Nanjing, Jiangsu | Recruiting | Apr 3, 2025 |
| Testing LXP1788 Injection for Advanced Solid Tumors | Phase 1 | Taichung and 1 other locations | Recruiting | Mar 19, 2025 |
| Evaluating a new PET imaging method for renal cell carcinoma | — | Xi'an, China, Shaanxi | Recruiting | Jan 10, 2025 |
All recruiting trials (4)
-
Cortical-plus-medullary versus medullary-only suturing for robot-assisted partial nephrectomy
This trial tests whether using only medullary stitches instead of both medullary and cortical stitches during robot-assisted partial nephrectomy helps protect kidney function and reduce operative time and blood loss for people with localized renal cell carcinoma.
-
Robot-assisted surgery for early-stage kidney tumors
This study is testing whether robot-assisted surgery without clamping the renal artery can safely and effectively treat early-stage kidney tumors while helping patients recover faster and keep their kidney function.
-
Testing LXP1788 Injection for Advanced Solid Tumors
This study is testing a new injection called LXP1788 to see if it can safely help people with advanced solid tumors that haven't responded to other treatments.
-
Evaluating a new PET imaging method for renal cell carcinoma
This study is testing a new type of PET scan to see if it can better diagnose and stage kidney cancer in patients who are suspected of having the disease.
Related topics
Quick answers
How many RCC, Renal Cell Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Taiwan (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.